Charles Schwab Investment Advisory, Inc. Becton Dickinson & CO Transaction History

Charles Schwab Investment Advisory, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$195.69 - $279.01 $249 Million - $355 Million	-1,272,257 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$236.45 - $266.82 $6.75 Million - $7.62 Million	28,559 Added 2.3%	1,272,257 $346 Million
Q3 2019 Nov 14, 2019	BUY	$230.58 - $256.08 $3.7 Million - $4.11 Million	16,032 Added 1.31%	1,243,698 $315 Million
Q2 2019 Aug 12, 2019	BUY	$217.4 - $246.08 $4.93 Million - $5.58 Million	22,678 Added 1.88%	1,227,666 $309 Million
Q1 2019 May 14, 2019	BUY	$206.05 - $248.17 $645,760 - $777,764	3,134 Added 0.26%	1,204,988 $301 Million
Q4 2018 Feb 13, 2019	SELL	$204.73 - $257.93 $703,657 - $886,505	-3,437 Reduced 0.29%	1,201,854 $271 Million
Q3 2018 Nov 14, 2018	SELL	$233.07 - $256.0 $2.36 Million - $2.59 Million	-10,135 Reduced 0.83%	1,205,291 $315 Million
Q2 2018 Aug 09, 2018	BUY	$208.1 - $233.85 $253 Million - $284 Million	1,215,426 New	1,215,426 $291 Million

1,796

258M

1.23M

866K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.1B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Advisory, Inc., based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Advisory, Inc. with notifications on news.